The advent of the new year seems an appropriate time to revisit the hot-button issue of “manifestation” in product defect cases. In some cases, a defective product fails to perform as intended from day one. In others, the defect remains latent, unknown to the consumer, until it “manifests,” sometimes resulting in severe physical injury. No matter whether the defect is latent or not, one expects that reasonable consumers would not be willing to pay the same price for a defective product compared to a non-defective product. As I have argued previously in this space, this economic injury should, at the very least, establish Article III standing in federal court. Significantly, the weight of recent authority on this point is in accord. See, e.g., Riddell v. General Motors LLC, 2024 WL 2077559 (E.D. Mo. May 9, 2024) (holding that Article III standing was satisfied for each class member given evidence of a class-wide vehicle defect).